Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 27  •  04:00PM ET
16.20
Dollar change
-0.11
Percentage change
-0.67
%
IndexRUT P/E11.44 EPS (ttm)1.42 Insider Own5.90% Shs Outstand12.18M Perf Week-0.86%
Market Cap196.79M Forward P/E11.92 EPS next Y1.36 Insider Trans0.00% Shs Float11.43M Perf Month10.20%
Enterprise Value220.81M PEG- EPS next Q0.34 Inst Own87.18% Short Float0.53% Perf Quarter7.36%
Income17.41M P/S4.34 EPS this Y17.96% Inst Trans0.50% Short Ratio2.24 Perf Half Y11.42%
Sales45.33M P/B0.80 EPS next Y-21.30% ROA5.74% Short Interest0.06M Perf YTD28.99%
Book/sh20.23 P/C24.57 EPS next 5Y- ROE6.58% 52W High17.90 -9.51% Perf Year23.24%
Cash/sh0.66 P/FCF6.78 EPS past 3/5Y-18.76% -10.11% ROIC6.25% 52W Low11.99 35.12% Perf 3Y15.51%
Dividend Est.- EV/EBITDA7.09 Sales past 3/5Y-6.20% 8.36% Gross Margin92.67% Volatility1.72% 2.47% Perf 5Y36.93%
Dividend TTM- EV/Sales4.87 EPS Y/Y TTM41.37% Oper. Margin61.17% ATR (14)0.40 Perf 10Y94.83%
Dividend Ex-DateApr 24, 2025 Quick Ratio3.17 Sales Y/Y TTM6.60% Profit Margin38.42% RSI (14)62.66 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio3.17 EPS Q/Q-17.45% SMA203.28% Beta0.22 Target Price18.50
Payout0.00% Debt/Eq0.13 Sales Q/Q-17.28% SMA507.91% Rel Volume0.60 Prev Close16.31
Employees24 LT Debt/Eq0.13 EarningsAug 14 AMC SMA20013.75% Avg Volume27.28K Price16.20
IPOSep 22, 1999 Option/ShortNo / Yes EPS/Sales Surpr.110.99% - Trades Volume16,335 Change-0.67%
Oct-09-25 06:00PM
Aug-16-25 03:04AM
Aug-14-25 05:15PM
Aug-07-25 07:30AM
Jul-31-25 08:30AM
07:29AM Loading…
Jul-17-25 07:29AM
Jul-15-25 05:00PM
May-15-25 04:30PM
May-09-25 07:30AM
Apr-10-25 04:15PM
Mar-20-25 01:45PM
Mar-19-25 09:20PM
09:10PM
Mar-13-25 07:30AM
Feb-07-25 11:00AM
07:35AM Loading…
Jan-06-25 07:35AM
Nov-14-24 04:15PM
Oct-17-24 04:15PM
Aug-15-24 08:15AM
Jul-17-24 04:15PM
Jul-08-24 05:00PM
May-19-24 08:08AM
May-15-24 10:54PM
04:05PM
Mar-23-24 05:33AM
Mar-21-24 01:53PM
07:00AM
Jan-23-24 04:05PM
Nov-09-23 07:30AM
Nov-06-23 04:05PM
08:00AM Loading…
Oct-30-23 08:00AM
Oct-18-23 08:00AM
Oct-11-23 08:00AM
Oct-03-23 04:05PM
Sep-28-23 06:34PM
Sep-26-23 04:07PM
Aug-17-23 09:00AM
Aug-09-23 04:05PM
Aug-08-23 08:00AM
Jul-27-23 05:43PM
Jul-17-23 04:05PM
Jun-28-23 04:05PM
May-11-23 09:00AM
07:00AM
May-02-23 04:36PM
Apr-03-23 07:30AM
Mar-31-23 08:00AM
SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company offers capital and investments in life science companies, institutions, and inventors. It operates through the Finance Receivables and Pharmaceutical Development segments. The Finance Receivables segment is a healthcare capital provider which offers customized financing solutions to a broad range of life science companies, institutions, and investors. It is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Pharmaceutical Development segment strategy is to utilize the Peptelligence platform to create a wholly-owned portfolio of milestone and royalty income by out-licensing the technology. The company was founded in July 1996 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Staggs Joe David JRPRESIDENTApr 15 '25Option Exercise11.2233,750378,525149,623Apr 17 04:34 PM